The impact of buprenorphine transdermal delivery system on activities of daily living among patients with chronic low back pain: an application of the international classification of functioning, disability and health.


OBJECTIVES The buprenorphine transdermal delivery system (BTDS) is indicated for reduction of pain in moderate to severe chronic low back pain (CLBP), which can affect patients' ability to perform routine activities of daily living (ADLs). This post hoc analysis of clinical trial data examines the impact of BTDS treatment on CLBP patients' ability to… (More)
DOI: 10.1097/AJP.0000000000000068


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics